TrialInternational journal of chronic obstructive pulmonary disease2015

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.

Chen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.